3:首次持股声明-董事 Zhang Hong
Estrella Immunopharma | SC 13D:超过5%持股股东披露文件-Eureka Therapeutics, Inc.(71.8%)
Estrella Immunopharma | 3:首次持股声明-首席财务官 Xu Jiandong
Estrella Immunopharma | 3:首次持股声明-董事 Roberts Marsha
Estrella Immunopharma | 3:首次持股声明-董事 Xu Pei
Estrella Immunopharma | 3:首次持股声明-首席执行官 Liu Cheng
Estrella Immunopharma | 3:首次持股声明-董事 Wu Xuejun Janelle
Estrella Immunopharma | 3:首次持股声明-董事 Wu Fan
Estrella Immunopharma | 3:首次持股声明-股东 Eureka Therapeutics, Inc.
Estrella Immunopharma | 4:持股变动声明-股东 Owl Creek Asset Management, L.P.
Estrella Immunopharma | 4:持股变动声明-其他相关方 TradeUP Acquisition Sponsor LLC
Estrella Immunopharma | 4:持股变动声明-其他相关方 Long James
Estrella Immunopharma | 4:持股变动声明-其他相关方 Jiang Tao
Estrella Immunopharma | 4:持股变动声明-其他相关方 Wen Luqi
Estrella Immunopharma | 4:持股变动声明-其他相关方 Li Jianwei
Estrella Immunopharma | 4:持股变动声明-其他相关方 Twigg Weston
Estrella Immunopharma | 4:持股变动声明-其他相关方 Yang Weiguang
Tradeup Acquisition Corp | SC 13G/A:超过5%持股股东披露文件(修正)-Karpus Investment Management(0%)
Tradeup Acquisition Corp | SC 13G/A:超过5%持股股东披露文件(修正)-ATW SPAC MANAGEMENT LLC(0.0%),Antonio Ruiz-Gimenez(0.0%)
Tradeup Acquisition Corp | SC 13G/A:超过5%持股股东披露文件(修正)-Karpus Investment Management(14.75%)
暂无数据
暂无数据